Adverum Biotechnologies (ADVM:NAS) and Concordia International (CXRX:NAS) Trading at Less than Cash Value

I have used the analysis tools on the website to generate some of the content of this blog post. These tools and reports are available for free at

Trading at Less than Cash Value

Today we are looking at companies trading at less than cash value meaning companies whose current share price is less than the cash per share on the balance sheet. We also show the value of cash net debt per share to show how much cash per share would be left if the debt was paid off.

What this Means…

Companies can have more cash per share than the actual share price for a number of reasons including they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or if there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a P/E greater than 0 and are worth exploring in more detail.

Today’s Data on NASDAQ

Today’s data is for companies listed on the NASDAQ.

Symbol Name Close Price Shares Outstanding P/E P/B Cash per Share Net Cash per Share
CZR Caesars Entertainment Corp 9.150000 147184937 None None 10.28 -36.18
TEDU Tarena International Inc 18.100000 56055497 30.8758 4.8238 18.27 None
YTRA Yatra Online Inc 8.380000 33809313 None 6.6531 85.15 83.68
CEMP Cempra Inc 3.600000 52392905 None 1.0287 4.42 4.13
AMCN AirMedia Group Inc 2.460000 62197822 None 0.4308 3.52 1.40
ADVM Adverum Biotechnologies Inc 2.750000 42063237 None 0.5365 5.28 1.20
CXRX Concordia International Corp 2.125000 51017004 None 0.3601 3.19 -60.38
GURE Gulf Resources Inc 1.990000 46789137 2.4875 0.2602 3.02 2.96
NVTR Nuvectra Corp 6.460000 10337753 None 0.6614 7.32 6.00
UTSI UTStarcom Holdings Corp 1.810000 36460201 None 0.6968 2.23 8.49
OREX Orexigen Therapeutics Inc 4.180000 14586771 None 0.8305 5.10 -8.67
BEBE bebe stores Inc 6.530000 8066805 None 0.4549 8.28 11.33
TRIL Trillium Therapeutics Inc 6.000000 7817883 None 1.8832 7.11 7.08
ITEK Inotek Pharmaceuticals Corp 1.700000 26930730 None 0.5383 3.08 1.27
APWC Asia Pacific Wire & Cable Corp Ltd 2.645000 13819669 12.0227 0.2534 3.09 0.44
GIGM GigaMedia Ltd 3.020000 11052235 None 0.5301 6.13 5.90
HSGX Histogenics Corp 1.840000 15930708 None 7.2628 2.38 2.33
ARDM Aradigm Corp 1.880000 14951089 None 3.3506 1.91 1.05
ABAC Aoxin Tianli Group Inc 2.508000 7988245 11.4000 0.2306 6.85 6.51
ONTX Onconova Therapeutics Inc 2.750000 6759895 None 2.0239 3.81 None
CYCC Cyclacel Pharmaceuticals Inc 4.090000 4251229 None 1.0264 4.24 2.70
GLBR Global Brokerage Inc 2.300000 5602559 4.5098 None 168.78 106.43
VISN VisionChina Media Inc 2.240000 5137098 None 0.3599 2.92 -10.13
KBSF KBS Fashion Group Ltd 5.950000 1767911 None 0.1056 14.63 13.73
CBIO Catalyst Biosciences Inc 6.540000 1000036 2.4222 0.3336 10.26 -9.14

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

ADVM:NAS Adverum Biotechnologies
Adverum Biotechnologies has 61 employees and is headquartered in United States.
Adverum Biotechnologies Inc is a gene therapy company committed to discovering and developing novel medicines that can offer potentially life-changing therapeutic benefit to patients living with rare diseases or diseases of the eye.

CXRX:NAS Concordia International
Concordia International has 214 employees and is headquartered in Canada.
Concordia International Corp is a diverse, international pharmaceutical company focused on legacy pharmaceutical products and orphan drugs. It has three business segments: Concordia North America, Orphan Drug Division and the Concordia International.

Free Valuation

Run a valuation on any of the companies listed above at or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.